The University of Sydney, Australia has signed a Memorandum of Understanding (MoU) with Pharos Therapeutics, the Austral...
South Korean firms HanAll Biopharma and Daewoong Pharmaceutical have entered into a co-development agreement with N...
Prime Minister Fumio Kishida has recently announced the Government of Japan's pledge to contribute&n...
South Korea-based Avixgen is currently having a strong pipeline in ophthalmic diseases such as age related macular degen...
Japanese firm Fujitsu has announced the commercial debut of its "Biodrug Design Accelerator," a platform to manage resea...
The US Food and Drug Administration (FDA) has announced the supplemental approval of Rexulti (brexpiprazole) o...
Japanese pharmaceutical firm Eisai Co. has entered into a joint development agreement with China-based startup Bliss Bio...
South Korea-based Daewoong Pharmaceutical has signed a Global License Agreement for its autoimmune disease drug can...
South Korean firm Daewoong Pharmaceutical has entered a research collaboration with UK-based Sygnature Discovery to expa...
Japanese pharmaceutical firm Eisai Co. has announced the completion of a major renovation of its Tsukuba Research Labora...
French firm Innate Pharma has entered into an exclusive license agreement with Japanese pharmaceutical company Takeda un...
Japan-based NEC Corporation announced in 2019 that it would expand the application of its cutting-edge artificial inte...
The Global Health Innovative Technology (GHIT) Fund, in Japan, has announced an investment totaling approximately 400 mi...
Genuv Inc., a clinical-stage biotechnology startup focused on drug discovery, and South Korea headquartred Celltrion, a ...
A company launched from Australia-based University of Queensland’s Institute for Molecular Bioscience (I...
A molecule discovered by Distinguished Professor Dame Margaret Brimble of the University of Auckland, New Zealand is the...
Hundreds of thousands of Australians with life-threatening high cholesterol are set to benefit from a revolutionary new ...
Japan-based pharmaceutical companies Teijin Limited and Axcelead, Inc. have jointly announced their basic agreemen...
